Seeking Alpha

ISTA Pharmaceuticals (ISTA) says during its guidance and pipeline update that it expects 2012...

ISTA Pharmaceuticals (ISTA) says during its guidance and pipeline update that it expects 2012 earnings and revenue to come in below estimates. It now expects its EPS to be between $0.28 - $0.39 on revenue of around $180M -$195M.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)